Search

everythinglearnresearchcommunity

for

Search:↓

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Leflunomide is more likely to help treat alopecia areata than cause it.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Skin cell-derived vesicles can help heal skin injuries effectively.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Vitamin D is important for skin health and can help treat and prevent various skin conditions.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Hyaluronic acid and polycaprolactone improve skin regeneration, with polycaprolactone having a stronger effect on healing and tissue repair.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.